argyrotsipi/train-dataset huggingface dataset:
Medical Research and Development (Israel) — House of Commons, 2017-03-23
Topic: Health
Thomas Anthony Brake (Liberal Democrats, Centre to centre-left): May I echo the opening words of the Secretary of State and indeed the condolences that have been expressed for the police officer and the families of others affected by this tragedy The world-leading Institute of Cancer Research in the London borough of Sutton already does a lot of work with Israel. Can the Secretary of State confirm whether the post-grads who work at the institute, a third of whom come from the European Union, will be able to carry on working in those projects for years to come?
NHS Shared Business Services — House of Commons, 2017-06-27
Topic: Health
Stephen Anthony Christopher Lloyd (Liberal Democrats, Centre to centre-left): Does the Secretary of State agree that this is a very straightforward case? It shows a woeful lack of transparency, is a good example of why so many of us have concerns about too much private sector involvement in the NHS and, bluntly, there is a conflict of interest for the Secretary of State.
Drugs Policy — House of Commons, 2017-07-18
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): The Minister says there are signs that the policy is working, but does she ever pause for thought when she sees the significant increase in the number of people dying from drug misuse in the past three years? That picture is not mirrored in other European countries that take a more enlightened approach.
Contaminated Blood Inquiry — House of Commons, 2017-11-14
Topic: Health
John Vincent Cable (Liberal Democrats, Centre to centre-left): The Minister will be aware that the integrity of blood products is underpinned by a common European agreement on standards. Can she reassure the House that she has spoken to other Ministers across Europe to ensure that, whether or not there is a deal, those standards will be fully maintained subsequent to Brexit?
Mental Health Workforce — House of Commons, 2017-10-10
Topic: Health
Timothy James Farron (Liberal Democrats, Centre to centre-left): The Secretary of State may know that because of a reduction in the number of mental health clinicians in Cumbria, the Cumbria Partnership NHS Foundation Trust has now chosen to end consultant psychiatric call-out care from 8 pm to 9 am. It would have started last week, but it is going to start in the next two or three weeks. That means, as I am sure he is aware, that it will not be possible to section people under the Mental Health Acts between those hours unless they are within an NHS facility. People in police stations, people in care homes and people at A&E departments will not be—
Five Year Forward View for Mental Health — House of Commons, 2017-10-10
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): The ‘Five Year Forward View’ suggested that the Government accepted the case for comprehensive maximum waiting time standards in mental health to match those in physical health. Given that children throughout the country are routinely waiting for months to start their treatment, may I ask what progress the Government are making with the introduction of a maximum waiting time standard for children’s mental health?
BAE Systems Military Air & Information Sites: Job Losses — House of Commons, 2017-10-10
Topic: Defense
Jamie Hume Stone (Liberal Democrats, Centre to centre-left): What are Her Majesty’s Government doing to sell the Type 31e frigate to the United States? The Secretary of State for Defence has mentioned that that is a possibility. Secondly, will the Minister urge the Secretary of State for International Trade to come to the Chamber to explain what exactly he is doing for BAE?
Maternity Safety Strategy — House of Commons, 2017-11-28
Topic: Health
Stephen Anthony Christopher Lloyd (Liberal Democrats, Centre to centre-left): I welcome the Secretary of State’s statement, like many others in the Chamber. He talked several times about learning lessons. As he knows, a recent report has highlighted that in my own trust, the East Sussex Healthcare NHS Trust, there were 19 stillbirths last year, which is a far higher percentage than in the rest of the UK. In the spirit of learning lessons, will he agree to someone in the Department of Health examining why that is the case?
Cyber-Warfare Defence — House of Commons, 2017-11-27
Topic: Defense
Alexander Morrison Carmichael (Liberal Democrats, Centre to centre-left): Is the Department looking at the recent Russian activity in this sphere, especially in Ukraine and Crimea, where it is clear that cyber-warfare has gone hand in glove with conventional warfare? The initiatives that the Minister has outlined today are very welcome, but does he understand that he also has to speak to and include other Departments, commercial interests and media outlets?
Lethal Autonomous Weapons — House of Commons, 2017-11-27
Topic: Defense
Joanne Kate Swinson (Liberal Democrats, Centre to centre-left): Weapons that can kill without human instruction or accountability are not science fiction, but a worrying potential reality with huge moral consequences. If we are to secure international agreement on the control of these lethal autonomous weapons, we need to start from a common understanding of the challenge, so will the Minister re-evaluate the UK’s definition of autonomous weapons systems to bring it into line with that of the United Nations?
NHS Continuing Care — House of Commons, 2017-11-27
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I suspect that I will not be alone in the House in having concerns about how NHS continuing care is operating these days. Concerns about the process will have been raised by the constituents of many hon. Members on both sides of the House. It is worth recognising that the process of NHS continuing care has always been fraught because a lot of money often turns on the outcome, and the families affected are often going through a very difficult time as they cope with a loved one with serious care needs. However, particular things are happening in the system now that seem to justify our spending some time on considering whether the current situation is acceptable As the NHS and the care system struggle with what I think are impossible finances, some wholly unacceptable practices are emerging around the country, some of which I want to deal with this evening. First, it is clear that a postcode lottery is emerging, with no democratic legitimacy at all. The massive variation in the acceptance rate for applications for NHS continuing care has no apparent justifiable explanation. The BBC’s "Inside Out East" programme made a freedom of information request about the period between July 2016 and July 2017. It found that Birmingham South Central clinical commissioning group rejected 75% of those assessed for NHS continuing care, whereas the figure for Tameside and Glossop CCG was just 5%. Given that this is public money, how can we possibly justify such an extraordinary variation without any democratic legitimacy? The BBC’s figures also showed that 73% of people in my constituency were turned down, but that the figure for Manchester was just 17%. These are not odd examples—there are enormous variations across the country. I would be grateful if the Minister could explain how these extraordinary variations are happening and what she and the Government intend to do about them.
NHS Continuing Care — House of Commons, 2017-11-27
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): The hon. Lady might well be right. That does not justify the variations, but it is a possible explanation for part of the problem Secondly, the number of people nationally who are found to be eligible is falling. The National Audit Office found that the proportion of people assessed as eligible for standard continuing healthcare by CCGs reduced from 34% in 2011-12 to 29% in 2015-16.
NHS Continuing Care — House of Commons, 2017-11-27
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I will come on to that point in a moment. We are seeing more and more cases of couples being forcibly separated, which is really shocking and a denial of their human rights, so I agree with the hon. Gentleman At the end of March 2017, 57,000 patients were eligible for continuing healthcare in England, which was down 1.6% on the previous quarter and 2.7% on the previous year. What possible explanation for that can there be? Demand is rising significantly every year across the country, yet the number of people entitled is going down. That must be due to decision makers imposing tougher eligibility criteria.
NHS Continuing Care — House of Commons, 2017-11-27
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I am aware of that. Often there is no change in such people’s condition, but sometimes their condition deteriorates. Sometimes the cost is pushed on to the local authority, but sometimes it is pushed on to the family, which is another very serious concern There are also a great many complaints about the process that is used. There are complaints about evidence being ignored, which can result in a judgment that someone is ineligible for NHS continuing care, and about professionals lacking an understanding of the condition that they are supposed to be considering. A survey conducted by the Continuing Healthcare Alliance found that 66% of people felt that professionals knew little about the condition that was under consideration. More seriously, there were allegations that medical opinions were being ignored. The BBC heard from three health workers who revealed, effectively as whistleblowers, that medical opinions were actively ignored as part of the process.
NHS Continuing Care — House of Commons, 2017-11-27
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): Depressingly, I have. Earlier this evening, when I was giving the Speaker’s lecture, I made the case that we need, ultimately, a pooled budget for both health and care to stop these awful arguments between the health and social care silos.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I beg to move, That this House notes with concern that there has been a systematic failure to inform women of the dangers of taking the epilepsy drug sodium valproate during pregnancy, resulting in thousands of children being born with congenital malformations, disabilities and developmental disorders since the 1970s as a result of fetal exposure to the drug; welcomes the launch of the Valproate Toolkit by the Medicines and Healthcare Products Regulatory Agency in February 2016 to ensure that women are informed of the potential risks of the drug, but further notes with concern a recent survey which found that 68 per cent of women have still not received these safety warnings; calls on the Government to take immediate steps to ensure that the materials in the Valproate Toolkit are distributed to all prescribing clinicians, pharmacists, and women who are being prescribed the drug; calls on the Government to require all clinicians prescribing sodium valproate to women and girls of childbearing age to discuss annually with the patient, the risks during pregnancy before a prescription is renewed; and further calls on the Government to bring forward proposals for a care plan and financial assistance to the victims of sodium valproate in pregnancy and their families I congratulate you, Madam Deputy Speaker, on getting through this debate’s catchy title I start by thanking the Backbench Business Committee, on behalf of the all-party parliamentary group on valproate and other anti-epileptic drugs in pregnancy, for facilitating this debate. I also pay tribute to Janet Williams and Emma Murphy, who are present today. They have fought tirelessly on this cause over many years, and we owe them an enormous debt of gratitude It is fair to say that "scandal" is an overused word in political discourse, but it is appropriate in this case: a family who have suffered as a result of a mother taking valproate in pregnancy would regard it as an absolute scandal, and we need to treat it in that way. There are many similarities to the thalidomide scandal. A group of women, over many years, took a drug during pregnancy without knowing the risks, with awful consequences, and we owe them a duty—that is the important point.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I thank the hon. Lady for her intervention, and I completely agree with her. Interestingly, the original product licence in March 1974 stated this, way back then: "In women of child bearing age, it should only be used in severe cases or those resistant to other treatments." They knew in the ’70s, yet the appalling scandal is that so many women since then have had their life turned completely upside down, with enormous consequences for their children, because they were not told.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Timothy James Farron (Liberal Democrats, Centre to centre-left): My constituent Nicola took sodium valproate through her pregnancy, and her son has chronic fatigue. The impact on her family is immense and expensive. We have fought for, and managed to secure, medical support for her through hospitals in Manchester, but does my right hon. Friend agree that there needs to be a Government fund to ensure that victims have such support, rather than having to rely on their own means?
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I completely agree. I will make the case a little later, but it seems unanswerable and the Government need to reflect on that What happened was worse than just the neglect of not telling women. The minutes from the 18 July 1973 meeting of the sub-committee on adverse reactions, a sub-committee of the Committee on Safety of Medicines, have been uncovered. That document reveals a real outrage, because it talks about keeping the information from women—deliberately withholding it "especially as it could give rise to fruitless anxiety." It continued: "Nevertheless, they thought it would be best if prescribers were all made aware of the nature of the evidence and recommended that a statement similar to that proposed by ICI"— in respect of another product— "could be included in all relevant data sheets but not on package inserts so that there would be no danger of patients themselves seeing it." That is extraordinary.
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): The hon. Lady is making an incredibly valuable contribution to the debate. Does she agree that if it is clear during a period of time that the amount of a drug that is being prescribed is significantly more than the guidance suggests is appropriate, it is not acceptable for the drug company, the regulator and the Government simply to be passive and to allow that to continue? If we knew that this drug was being over-prescribed, which appears to be the case, why on earth was action not taken?
Valproate and Foetal Anticonvulsant Syndrome — House of Commons, 2017-10-19
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I sincerely thank all right hon. and right hon. Members for participating in today’s incredibly well-informed, responsible and powerful debate. This is a fight for justice. The Minister is right that we have a meeting planned for 7 December with his colleague the noble Lord O’Shaughnessy, and I hope very much that by then, the Government will have reached a view on the case for compensation. The Government have a choice: they can either deny the unanswerable moral case for treating these people properly, or they can take the moral lead and accept that the state has a responsibility to these families. I hope very much that they do the latter Question put and agreed to. Resolved, That this House notes with concern that there has been a systematic failure to inform women of the dangers of taking the epilepsy drug sodium valproate during pregnancy, resulting in thousands of children being born with congenital malformations, disabilities and developmental disorders since the 1970s as a result of fetal exposure to the drug; welcomes the launch of the Valproate Toolkit by the Medicines and Healthcare Products Regulatory Agency in February 2016 to ensure that women are informed of the potential risks of the drug, but further notes with concern a recent survey which found that 68 per cent of women have still not received these safety warnings; calls on the Government to take immediate steps to ensure that the materials in the Valproate Toolkit are distributed to all prescribing clinicians, pharmacists, and women who are being prescribed the drug; calls on the Government to require all clinicians prescribing sodium valproate to women and girls of childbearing age to discuss annually with the patient, the risks during pregnancy before a prescription is renewed; and further calls on the Government to bring forward proposals for a care plan and financial assistance to the victims of sodium valproate in pregnancy and their families.
Defence Aerospace Industrial Strategy — House of Commons, 2017-11-16
Topic: Defense
Jamie Hume Stone (Liberal Democrats, Centre to centre-left): Perhaps it is right and proper if I inform the Chamber at this point that my daughter is a serving officer in the Royal Air Force. I am new to this brief, but I read the proceedings of the Defence Committee on 25 October with the greatest of interest, and I want to emphasise two points. The first is about the P-8 and our involvement in that aircraft. I suppose that there was nothing else we could do at the time—it was two years ago—but I have to say for the record that I am unhappy that we did not look to British industry to build or develop the aircraft, but perhaps we had no choice. However, let us not make any mistake about our friends in Boeing—I only have to say one word: Bombardier. That situation underlines the crucial importance of a strategy for our future aero-defence industry Secondly, to pick up on the point of the hon. Member for Witney (Robert Courts), let us remember why we won the second world war. In the 1920s, the 1930s and the 1940s, our air defence industry was broadly based, had expertise and was innovative. If one studies one’s history, one finds that we actually out-designed and out-built our foes. In that conflict, our aircraft were without question the best in the world. That is what is at stake for the defence of this country. This is extremely important and history speaks to that My time is almost finished, Madam Deputy Speaker. I apologise that you were not told that I was the Liberal Democrat defence spokesman, so I shall conclude with this: I represent the Tain weapons range and Cape Wrath, where NATO and our forces practise and drop their weapons. I hope very much to see a sixth-generation fighter aircraft flying over my constituency before they put me in a wooden box and carry me away.
NHS Pay — House of Commons, 2017-09-13
Topic: Health
Norman Peter Lamb (Liberal Democrats, Centre to centre-left): I agree that we have to treat people with justice across the public sector to ensure that they are not unfairly and unreasonably left behind On the comments made by the hon. Member for Totnes (Dr Wollaston), behind this issue is the inescapable question of the amount of money that we are putting into health and care services, because that ultimately determines how much we can pay and how many people we can employ. The bottom line is that we cannot carry on as we are; it is not sustainable. We are not being honest with the British people. The truth is that, at the last election, none of the political parties had a solution for the NHS and the care system. I was challenged earlier about the fact that the Lib Dems argued for a 1p increase in income tax. I absolutely acknowledge that that is not a panacea and would not solve all the problems, but it would provide an immediate £6 billion, which would have a big impact on the sustainability of the system The bottom line is that we need to work together across the party divide. If we do not, we will be letting down the people of this country. We can continue to shout at each other, but that does not help the family whose loved one is let down by failures of care because the NHS and the care system do not have sufficient resources. More than 1 million older people have care needs that are not being met because of the underfunding in social care. As the Independent Age UK survey showed, well over 80% of Members of Parliament, on both sides of the House, agree that we need to work together to come up with a long-term, sustainable solution. Please, Government, get on with it.
Nuclear Safeguards Bill — House of Commons, 2017-10-16
Topic: Health
Layla Michelle Moran (Liberal Democrats, Centre to centre-left): Does the hon. Gentleman agree that is not about the EU wanting to give us radioisotopes, but about half-lives? The radioisotopes we are talking about have extremely short half-lives, so any delay at all at the border means fewer patients will be able to benefit from them.
Covid-19: Purchasing Effort — House of Commons, 2022-02-03
Topic: Health
Helen Margaret Lilian Morgan (Liberal Democrats, Centre to centre-left): As a chartered accountant, I am au fait with the concept of an accounting write down and the scale of this one really does indicate reckless waste. I am sure that, in my constituency of North Shropshire, the £9.7 billion carelessly wasted could have been put to better use. It could have been used to tackle the extremely high ambulance waiting times, to help the local accident and emergency tackle the huge challenges it faces in getting patients through, or to deal with the £50 million black hole that social care in Shropshire is facing in two years’ time. Across the country, the story is very much the same. Local health services are struggling to find the money to deal with those issues. I am sure Members across the House know those issues all too well. That is why £9.7 billion wasted on PPE is so shocking. What are the Government doing to allocate resources to sufficiently recover that money?
Vaccination: Condition of Deployment — House of Commons, 2022-01-31
Topic: Health
Daisy Cooper (Liberal Democrats, Centre to centre-left): I welcome this change of tack because I, like many others, opposed the compulsory vaccination policy. However, I fear that, in the care sector, the damage has been done—there are reports that about 40,000 people have already left—and it is damaging patient safety. With the change of tack, will the Secretary of State tell us his plans to get more carers quickly into the sector? With regard to the shortage occupation list, how many carers does he hope to recruit, and by when?
Covid-19 Update — House of Commons, 2022-01-05
Topic: Health
Helen Margaret Lilian Morgan (Liberal Democrats, Centre to centre-left): Thank you, Mr Speaker Ambulance services and paramedics are desperately struggling to maintain a safe and timely service across the country. My constituency of North Shropshire is no exception, and inexplicably has seen two of its ambulance stations closed, as well as waiting times sky-rocket. With the crisis in emergency care escalating, will the Prime Minister commit today before this House to supporting my call for a full and proper review of ambulance services by the Care Quality Commission?
Ukraine — House of Commons, 2022-01-25
Topic: Defense
Jamie Hume Stone (Liberal Democrats, Centre to centre-left): It is not just Ukraine; we have military forces in Estonia, which is a member of NATO and a true friend of the UK. The Prime Minister said that if Russia invades Ukraine, we will bolster up our NATO allies. Should we not have more forces in Estonia now?